Today's Top 20 StoriesRSS
Neuralstem announced that the first patient was treated last week in the Phase I trial testing of NSI-566 human neural stem cells in the treatment of chronic spinal cord injury at the UC San Diego School of Medicine.  
A great bedside manner can help significantly improve patient experience and satisfaction. Six spine surgeons discuss what constitutes a good bedside manner and how to improve it.  
  Here are eight things for spinal surgeons to know for Oct. 9, 2014.  
NuVasive COO Keith Valentine sold 2,500 shares of the company's stock last week, valued at $35 per share, according to a WKRBB report. 
An article published in Spine examined how smoking impacted posterolateral fusions. 
Los Angeles-based Cedars-Sinai Health System finalized an agreement to affiliate with Kerlan-Jobe Orthopaedic Clinic in Los Angeles and Santa Monica (Calif.) Orthopaedic and Sports Medicine Group.  
  The Food and Drug Administration cleared 37 orthopedic- and spine-related devices in September.  
  An article published in the Journal of Neurosurgery: Spine examines the seven-year follow-up for patients who received the Prestige artificial disc in a prospective randomized controlled clinical trial.  
Can you imagine a world without "Hurt So Good," "Jack & Diane," "Small Town," "R.O.C.K. in the U.S.A." and countless other John Mellencamp classics? 
Nevro Corp., announced an initial public offering last Friday as the company attempts to gain regulatory clearance for its pain-relief system in the United States, according to a NASDAQ report. 
Medical device manufacturer BD plans to acquire CareFusion for $12.2 billion. 
European Union regulators have begun an in-depth probe into Zimmer's planned acquisition of Biomet, according to a Wall Street Journal report.  
Mission Viejo, Calif.-based Mission Hospital will begin admitting patients to $185 million Neuroscience and Spine Institute on Oct. 13, according to an Orange County Register report.  
Here are seven orthopedic surgeons who have treated or will soon treat professional athletes.  
Healthcare is moving head-first toward shared-risk and shared-savings care delivery models. The most progressive organizations are testing accountable care organizations, bundled payments and narrow networks to reduce waste and improve outcomes. But can they work? 
Gerbsman Partners has been hired to sell AxioMed Spine, accompany that has raised more than $70 million, according to the Blog of Intellectual Capital. 
The medtech market is expected to grow over the next six year as several external factors impact markets around the world, according to a report from EvaluateMedTech.  
  Mazor Robotics reported five Renaissance robotic spine surgery systems during the third quarter.  
An article published in Spine examines the results of revision spine surgery after pedicle subtraction osteotomy for fixed sagittal imbalance with pseudarthrosis. 
The orthobiologics market in Asia is estimated to grow to around $0.7 billion by 2018, according to a MicroMarket Monitor report.  
Page 6 of 221